Chemours officer receives RSU grant, shares withheld

Chemours executive Gerardo Familiar Calderon reported equity compensation changes involving company common stock.

Rhea-AI Filing Summary

Chemours executive Gerardo Familiar Calderon reported equity compensation changes involving company common stock. He received a grant of 25,708 shares of common stock at a price of $0.0000 per share as a grant, award, or other acquisition, structured as restricted stock units and related dividend equivalent units.

Separately, 2,635 shares were automatically withheld at $18.24 per share to satisfy tax obligations upon vesting of existing restricted stock units; footnotes state that no shares were sold and the transaction is exempt under Rule 16b-3. The new RSU award is scheduled to vest in three equal annual installments beginning on March 1, 2027, and the reported holdings include directly owned shares, RSUs, and dividend equivalent units.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Familiar Calderon Gerardo

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	25,708	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,635	$18.24	$48K

Holdings After Transaction: Common Stock — 57,292.1467 shares (Direct)

Footnotes (3)

1. F1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units ("RSUs") and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
2. F2. RSU award scheduled to vest in three equal annual installments beginning on March 1, 2027.
3. F3. Includes directly owned shares, RSUs and dividend equivalent units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider stock transactions did Chemours (CC) report for Gerardo Familiar Calderon?

Chemours reported that Gerardo Familiar Calderon received a grant of 25,708 common shares at $0.0000 per share and had 2,635 shares automatically withheld at $18.24 per share to cover tax obligations on vesting restricted stock units.

Was the Chemours (CC) insider disposition by Gerardo Familiar Calderon an open-market sale?

No, the disposition was not an open-market sale. Footnotes state 2,635 shares were automatically withheld to satisfy tax liabilities on vesting restricted stock units, with no shares sold, and that the transaction is exempt from Section 16(b) under Rule 16b-3.

What are the terms of Gerardo Familiar Calderon’s new RSU award at Chemours (CC)?

The new restricted stock unit award is scheduled to vest in three equal annual installments beginning on March 1, 2027. The award covers 25,708 shares of Chemours common stock, including related dividend equivalent units as described in the filing footnotes.

How many Chemours (CC) shares and units did Gerardo Familiar Calderon hold after the RSU grant?

After the RSU grant transaction, Gerardo Familiar Calderon’s reported holdings totaled 57,292.1467 Chemours common shares, restricted stock units, and dividend equivalent units, combining directly owned shares with the awarded RSUs and related units as indicated in the ownership footnote.

How is the tax-withholding transaction for Chemours (CC) insider Gerardo Familiar Calderon classified?

The tax-withholding transaction is coded “F,” described as payment of tax liability by delivering securities. It represents a disposition of 2,635 shares used to cover taxes on vesting RSUs, with no open-market sales reported for this insider transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 08:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Familiar Calderon Gerardo

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		F		2,635(1)	D	$18.24	31,584.1467	D
Common Stock	03/02/2026		A		25,708(2)	A	$0	57,292.1467(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units ("RSUs") and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

2. RSU award scheduled to vest in three equal annual installments beginning on March 1, 2027.

3. Includes directly owned shares, RSUs and dividend equivalent units.

Remarks:

President, Advanced Performance Materials

	/s/ Eric Stein, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.